Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.

Kaul U, Bangalore S, Seth A, Arambam P, Abhaichand RK, Patel TM, Banker D, Abhyankar A, Mullasari AS, Shah S, Jain R, Kumar PR, Bahuleyan CG, TUXEDO–India Investigators

Open source

DOI: 10.1056/nejmoa1510188
Published: 2015 Oct 29
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1510188,
  title = {Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.},
  author = {Kaul U and Bangalore S and Seth A and Arambam P and Abhaichand RK and Patel TM and Banker D and Abhyankar A and Mullasari AS and Shah S and Jain R and Kumar PR and Bahuleyan CG and TUXEDO–India Investigators},
  year = {2015},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1510188},
  url = {https://doi.org/10.1056/nejmoa1510188}
}

RIS

TY  - JOUR
TI  - Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.
AU  - Kaul U
AU  - Bangalore S
AU  - Seth A
AU  - Arambam P
AU  - Abhaichand RK
AU  - Patel TM
AU  - Banker D
AU  - Abhyankar A
AU  - Mullasari AS
AU  - Shah S
AU  - Jain R
AU  - Kumar PR
AU  - Bahuleyan CG
AU  - TUXEDO–India Investigators
PY  - 2015
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1510188
UR  - https://doi.org/10.1056/nejmoa1510188
ER  -

APA

U, K., S, B., A, S., P, A., RK, A., TM, P., D, B., A, A., AS, M., S, S., R, J., PR, K., CG, B., & Investigators, T. (2015). Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1510188

Source records

pubmed · retrieved 2026-09-26T14:53:14.874Z